Načítá se...
P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
The P2RX7 receptor is a unique member of a family of extracellular ATP (eATP)-gated ion channels expressed in immune cells, where its activation triggers the inflammatory cascade. Therefore, P2RX7 has been long investigated as a target in the treatment of infectious and inflammatory diseases. Subseq...
Uloženo v:
| Vydáno v: | Front Chem |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6032550/ https://ncbi.nlm.nih.gov/pubmed/30003075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fchem.2018.00248 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|